Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. annual/quarterly long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Vivos Therapeutics, Inc. long term debt for the quarter ending December 31, 2025 were 753,000, a 40.47% decrease year-over-year.
- Vivos Therapeutics, Inc. long term debt for 2025 were 753,000, a 40.47% decrease from 2021.
- Vivos Therapeutics, Inc. long term debt for 2021 were 1.3M, a 1.94% decrease from 2020.
- Vivos Therapeutics, Inc. long term debt for 2020 were 1.3M, a 65.22% decrease from 2019.
- Vivos Therapeutics, Inc. long term debt for 2019 were 3.7M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Vivos Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $1 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $4 |
| Vivos Therapeutics, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $1 |
| 2021-12-31 | $1 |
| 2020-12-31 | $1 |
| 2019-12-31 | $4 |
Vivos Therapeutics, Inc. Long Term Debt — FAQ
Vivos Therapeutics, Inc. (VVOS) long term debt over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VVOS's long term debt history?
The chart and table above show Vivos Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.